Round-up of trading updates for end of 2016
Pharmaceuticals are 'getting away with murder'
Why most regulation is 'common sense' and expansion plans
New report issued by lobby group
Emiel van den Heiligenberg, head of asset allocation at Legal & General Investment Management (LGIM), distils his outlook for 2017 into seven key questions facing investors this year.